Overview of the recent advances in systemic chemotherapy of gastroenteropancreatic neuroendocrine carcinoma
10.3760/cma.j.cn113884-20200619-00331
- VernacularTitle:胃肠胰神经内分泌癌全身化疗的研究进展
- Author:
Jun LIU
;
Wenbing SUN
;
Jun GAO
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(3):227-231
- CountryChina
- Language:Chinese
-
Abstract:
Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a rare and poorly differentiated tumor with poor prognosis. Although radical surgical treatment is the most preferred treatment for GEP-NEC, postoperative recurrence rate is still high. Many patients diagnosed at the late stage lost the chances to receive the surgery treatment. Therefore, systemic chemotherapy plays a particularly important role in the comprehensive treatment of GEP-NEC. The purpose of this paper is to systematically summarize and review the research progress of GEP-NEC systemic chemotherapy.
